238 related articles for article (PubMed ID: 27106876)
1. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW
Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
Knopf KM; Murphy BL; MacMillan SN; Baskin JM; Barr MP; Boros E; Wilson JJ
J Am Chem Soc; 2017 Oct; 139(40):14302-14314. PubMed ID: 28948792
[TBL] [Abstract][Full Text] [Related]
3. Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agents.
Pan ZY; Cai DH; He L
Dalton Trans; 2020 Aug; 49(33):11583-11590. PubMed ID: 32766642
[TBL] [Abstract][Full Text] [Related]
4. Mono- and dicationic Re(I)/(99m)Tc(I) tricarbonyl complexes for the targeting of energized mitochondria.
Moura C; Mendes F; Gano L; Santos I; Paulo A
J Inorg Biochem; 2013 Jun; 123():34-45. PubMed ID: 23507077
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.
Konkankit CC; Vaughn BA; MacMillan SN; Boros E; Wilson JJ
Inorg Chem; 2019 Mar; 58(6):3895-3909. PubMed ID: 30793900
[TBL] [Abstract][Full Text] [Related]
6. Comparative Study of Sonodynamic and Photoactivated Cancer Therapies with Re(I)-Tricarbonyl Complexes Comprising Phenanthroline Ligands.
Kushwaha R; Singh V; Peters S; Yadav AK; Sadhukhan T; Koch B; Banerjee S
J Med Chem; 2024 Apr; 67(8):6537-6548. PubMed ID: 38603561
[TBL] [Abstract][Full Text] [Related]
7. Recent development of luminescent rhenium(i) tricarbonyl polypyridine complexes as cellular imaging reagents, anticancer drugs, and antibacterial agents.
Lee LC; Leung KK; Lo KK
Dalton Trans; 2017 Dec; 46(47):16357-16380. PubMed ID: 29110007
[TBL] [Abstract][Full Text] [Related]
8. Underestimated potential of organometallic rhenium complexes as anticancer agents.
Leonidova A; Gasser G
ACS Chem Biol; 2014 Oct; 9(10):2180-93. PubMed ID: 25137157
[TBL] [Abstract][Full Text] [Related]
9. Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives.
Schindler K; Zobi F
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056856
[TBL] [Abstract][Full Text] [Related]
10. Rhenium complexes with visible-light-induced anticancer activity.
Kastl A; Dieckmann S; Wähler K; Völker T; Kastl L; Merkel AL; Vultur A; Shannan B; Harms K; Ocker M; Parak WJ; Herlyn M; Meggers E
ChemMedChem; 2013 Jun; 8(6):924-7. PubMed ID: 23568508
[TBL] [Abstract][Full Text] [Related]
11. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
12. Impairment of the autophagy-related lysosomal degradation pathway by an anticancer rhenium(i) complex.
He L; Pan ZY; Qin WW; Li Y; Tan CP; Mao ZW
Dalton Trans; 2019 Mar; 48(13):4398-4404. PubMed ID: 30864598
[TBL] [Abstract][Full Text] [Related]
13. Rhenium(IV) compounds inducing apoptosis in cancer cells.
Martínez-Lillo J; Mastropietro TF; Lappano R; Madeo A; Alberto ME; Russo N; Maggiolini M; De Munno G
Chem Commun (Camb); 2011 May; 47(18):5283-5. PubMed ID: 21448489
[TBL] [Abstract][Full Text] [Related]
14. Toward hypoxia-selective rhenium and technetium tricarbonyl complexes.
North AJ; Hayne DJ; Schieber C; Price K; White AR; Crouch PJ; Rigopoulos A; O'Keefe GJ; Tochon-Danguy H; Scott AM; White JM; Ackermann U; Donnelly PS
Inorg Chem; 2015 Oct; 54(19):9594-610. PubMed ID: 26375592
[TBL] [Abstract][Full Text] [Related]
15. Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates.
Montesdeoca N; Borkar RL; Sathiyendiran M; Karges J
Chemistry; 2024 Jun; 30(32):e202400217. PubMed ID: 38574234
[TBL] [Abstract][Full Text] [Related]
16. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
[TBL] [Abstract][Full Text] [Related]
17. Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes.
Leonidova A; Pierroz V; Rubbiani R; Heier J; Ferrari S; Gasser G
Dalton Trans; 2014 Mar; 43(11):4287-94. PubMed ID: 23982882
[TBL] [Abstract][Full Text] [Related]
18. Rhenium(I) polypyridine dibenzocyclooctyne complexes as phosphorescent bioorthogonal probes: Synthesis, characterization, emissive behavior, and biolabeling properties.
Choi AW; Liu HW; Lo KK
J Inorg Biochem; 2015 Jul; 148():2-10. PubMed ID: 25798989
[TBL] [Abstract][Full Text] [Related]
19. A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complex.
Kitanovic I; Can S; Alborzinia H; Kitanovic A; Pierroz V; Leonidova A; Pinto A; Spingler B; Ferrari S; Molteni R; Steffen A; Metzler-Nolte N; Wölfl S; Gasser G
Chemistry; 2014 Feb; 20(9):2496-507. PubMed ID: 24464824
[TBL] [Abstract][Full Text] [Related]
20. Influence of the metal center and linker on the intracellular distribution and biological activity of organometal-peptide conjugates.
Hu W; Splith K; Neundorf I; Merz K; Schatzschneider U
J Biol Inorg Chem; 2012 Feb; 17(2):175-85. PubMed ID: 21898043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
